Phase 3 Clinical Trial of GSK's Herpes Zoster Vaccine Candidate Containing Agenus' QS-21 Commences in Immunocompromised Patients
July 18, 2012 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., July 18, 2012 (GLOBE NEWSWIRE) -- Agenus, Inc. (Nasdaq:AGEN) today announced that GlaxoSmithKline's (GSK) herpes zoster vaccine candidate (HZ/su), which contains Agenus' QS-21...
Agenus to Join Russell 3000 Index, Global Index, and MicroCap Index
June 18, 2012 09:51 ET
|
Agenus Inc.
LEXINGTON, Mass., June 18, 2012 (GLOBE NEWSWIRE) -- Agenus, Inc. (Nasdaq:AGEN), a biotechnology company working to develop treatments for cancers and infectious diseases, today announced that it is...
Agenus to Webcast 2012 Annual Shareholders Meeting
June 01, 2012 12:15 ET
|
Agenus Inc.
LEXINGTON, Mass., June 1, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) invites investors and the general public to its 2012 Annual Shareholders Meeting at 5:00 p.m. ET on Wednesday, June 13th....
Agenus Reports First Quarter 2012 Financial Results and Corporate Updates
April 25, 2012 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., April 25, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) reported today its results for the first quarter ended March 31, 2012. The company reported net income attributable to...
New Phase 2 Data From Brain Cancer Study With Agenus' Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS
April 17, 2012 10:30 ET
|
Agenus Inc.
LEXINGTON, Mass., April 17, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) today announced that an abstract entitled, "A Phase 2 multicenter trial of autologous heat shock protein-peptide vaccine...
Agenus' Brain Cancer Vaccine Phase 2 Study to be Presented at Plenary Session of the 80th American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
April 02, 2012 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., April 2, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) reported today that Dr. Andrew Parsa, Professor in Residence, Department of Neurological Surgery, University of California...
Shalini Sharp Gets Appointed to Agenus' Board of Directors
March 20, 2012 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., March 20, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) today announced the appointment of Shalini Sharp to its board of directors effective May 11, 2012. Ms. Sharp has served...
Agenus Reports Fourth Quarter and Year End 2011 Financial Results and Corporate Updates
March 05, 2012 08:30 ET
|
Agenus Inc.
In the First Quarter 2012, Agenus Increased Its Cash Position by Approximately $18 Million
Agenus to Host Conference Call Beginning at 11 am ET Today
LEXINGTON, Mass., March 5, 2012...
Agenus Expands QS-21 License and Grants Right of First Negotiation to GlaxoSmithKline
March 05, 2012 08:30 ET
|
Agenus Inc.
Agenus to Receive $9 Million Upfront
Agenus to Host a Conference Call at 11 am ET Today
LEXINGTON, Mass., March 5, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) announced today that...
Agenus to Present at the 2012 Cowen Health Care Conference
March 01, 2012 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., March 1, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be...